<!DOCTYPE html>
<html lang="en">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Moe Capital</title>

	<style> 
		@media (prefers-color-scheme: dark){
		body {color:#fff;background:#000}
		a:link {color:#9cf}
		a:hover, a:visited:hover {color:#cef}
		a:visited {color:#c9f}
	}
	body{
		margin:1em auto;
		max-width:30em;
		padding:0 .62em;
		font:3vw Roboto,-apple-system,BlinkMacSystemFont,Helvetica Neue,Segoe UI,Oxygen,Ubuntu,Cantarell,Open Sans,Helvetica, Arial,sans-serif;		
		text-align:left;
		background: #001724;
		color: #f5f5f5;
	        letter-spacing: .01em;
		line-height: 1;
		
	}
	a {
             color: #ffdc09;
        }
	@media print{
		body{
			max-width:none
		}
	h1 {
		font-size:5rem;
	}
	h2 {
		font-size:3rem;
	}
	h3 {
		font-size:2rem;
	}
}
		</style>
<article>
	<header>
		<h1>Moe's US stock investing ideas </h1>
		</header>
	<p>
		Hello, We are Moe Capital and we provide market insights and help you invest wisely.
	</p>
	<p> We are popular as @MoneyAcademyKE on: <a href="https://twitter.com/MoneyAcademyKE" >Twitter</a>,
		<a href="https://t.me/MoneyAcademyKE" >Telegram</a> <a href="https://moneyacademy.substack.com/">Substack</a> and <a href="https://wa.me/+25469000111?text=I'm%20interested%20in%20your%20whatsapp%20news%20updates" >Whatsapp</a>
	</p>
		
	<p>𝐓𝐡𝐢𝐬 𝐢𝐬 𝐍𝐎𝐓 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐀𝐝𝐯𝐢𝐜𝐞.</p>
	<p>Last update date:3rd June 2024</p>

        <div>
            <h3>Mastercard $MA</h3>
            <p>
                NTM P/E: 30.34x6 </br>
                5-Year Avg: 35.37x </br>
                Estimated EPS Growth 2025: 16.2%</br>
                Estimated EPS Growth 2026: 17.0%</br>
                LTM ROIC: 64.1%</br>
            
                </p>
            
            <details>
    <summary>Mastercard valuation analysis</summary>
    <div>
        <details>
    <summary>Financial Numbers</summary>
    <div>
        ROIC: 64.1%
    </div>
</details>

	    <details>
    <summary>Financial Numbers</summary>
    <div>
        ROIC: 64.1%
    </div>
</details>
    </div>
</details>
            </div>

        <div>
            <h3>Salesforce $CRM</h3>
            <p>
NTM P/E: 23.30x</br>
5-Year Avg: 48.15x</br>
Estimated EPS Growth 2026*: 11.5%</br>
Estimated EPS Growth 2027*: 14.5%</br>
LTM ROIC: 9.1%</br>
                </p>
		<details>
    <summary>Salesforce valuation analysis </summary>
    <div>
NTM P/E Ratio: 23.30x</br>
•3-Year Mean: 38.89x</br>
•NTM FCF Yield: 5.18%</br>
•3-Year Mean: 3.68%</br>
</br>
As you can see, $CRM appears to be trading below fair value</br>
</br>
Going forward, investors can expect to receive ~67% MORE in earnings per share & ~40% MORE in FCF per share🧠***</br>
</br>
Before we get into valuation, let’s take a look at why $CRM is a good business </br>
</br>
BALANCE SHEET✅</br>
•Cash & Equivalents: $14.19B</br>
•Long-Term Debt: $8.43B</br>
</br>
$CRM has an excellent balance sheet, an A+ S&P Credit Rating & 352x FFO Interest Coverage Ratio</br>
</br>
RETURN ON CAPITAL🆗</br>
•2020: 1.2%</br>
•2021: 0.9%</br>
•2022: 0.8%</br>
•2023: 2.5%</br>
•2024: 8.2%</br>
</br>
RETURN ON EQUITY🆗</br>
•2020: 0.5%</br>
•2021: 10.8%</br>
•2022: 2.9%</br>
•2023: 0.4%</br>
•2024: 7.0%</br>
</br>
$CRM return metrics are ok, although more recently trending in the right direction</br>
</br>
REVENUES✅</br>
•2014: $4.07B</br>
•2024: $34.86B</br>
•CAGR: 23.95%</br>
</br>
FREE CASH FLOW✅</br>
•2014: $576.36M</br>
•2024: $9.49B</br>
•CAGR: 32.34%</br>
</br>
NORMALIZED EPS✅</br>
•2014: $0.35</br>
•2024: $8.22</br>
•CAGR: 37.11%</br>
</br>
SHARE BUYBACKS❌</br>
•2014 Shares Outstanding: 597.61M</br>
•LTM Shares Outstanding: 984.00M</br>
</br>
By increasing its shares outstanding ~64%, $CRM diluted its EPS by ~39% (assuming 0 growth)</br>
</br>
MARGINS✅</br>
•LTM Gross Margins: 75.5%</br>
•LTM Operating Margins: 17.2%</br>
•LTM Net Income Margins: 11.9%</br>
</br>
***NOW TO VALUATION 🧠</br>
</br>
As stated above, investors can expect to receive ~67% MORE in EPS & ~40% MORE FCF per share </br>
</br>
Using Benjamin Graham’s 2G rule of thumb, $CRM has to grow earnings at an 11.65% CAGR over the next several years to justify its valuation</br>
</br>
Today, analysts anticipate 2025 - 2027 EPS growth over the next few years to be  slightly more than the (11.65%) required growth rate:</br>
</br>
2025E: $9.91 (20.5% YoY) *FY Jan</br>
2026E: $11.05 (11.5% YoY)</br>
2027E: $12.65 (14.5% YoY)</br>
</br>
$CRM has an excellent track record of meeting analyst estimates ~2 years out, so let’s assume $CRM ends 2027 with $12.65 in EPS & see its CAGR potential assuming different multiples</br>
</br>
25x P/E: $316.25💵 … ~12.5% CAGR</br>
</br>
24x P/E: $303.60💵 … ~10.8% CAGR</br>
</br>
23x P/E: $290.95💵 … ~9.1% CAGR</br>
</br>
As you can see, we’d have to assume >24x earnings for $CRM to have double digit CAGR potential (a multiple justified by its growth rate & moat)</br>
</br>
Today at $234.44💵 $CRM appears to be worthwhile consideration for investment especially when you assess the trajectory of the company’s FCF & Net Income margins (steadily trending higher with further room to expand)</br>
</br>
To ensure some margin of safety, if there’s further weakness, it could be wise to piece into the position, for example:</br>
</br>
Initiating ~50% of the position at ~$234💵 & adding a second tranche at ~$200💵 or at ~20x NTM earnings</br>
    </div>
</details>
            </div>
    <div>
            <h3>Moët Hennessy Louis Vuitton $LVMH</h3>
            <p>
NTM P/E: 22.21x</br>
5-Year Avg: 27.26x</br>
Estimated EPS Growth 2025: 11.3%</br>
Estimated EPS Growth 2026: 8.9%</br>
LTM ROIC: 21.0%</br>
                </p>
	    
	    <details>
    <summary>LVMH valuation analysis</summary>
    <div>
        ...
    </div>
</details>
            </div>
    <div>
            <h3>Accenture $ACN</h3>
            <p>
NTM P/E: 22.84x</br>
5-Year Avg: 27.55x</br>
Estimated EPS Growth 2025: 8.6%</br>
Estimated EPS Growth 2026: 12.2%</br>
LTM ROIC: 32.3%</br>
                </p>
	    <details>
    <summary>Accenture valuation analysis</summary>
    <div>
•NTM P/E Ratio: 23.04x </br>
•10-Year Mean: 24.03x</br>
</br>
•NTM FCF Yield: 5.78%</br>
•10-Year Mean: 5.18%</br>
</br>
As you can see, $ACN appears to be trading slightly below fair value</br>
</br>
Going forward, investors can expect to receive ~4% MORE in earnings per share & ~11% MORE in FCF per share🧠***</br>
</br>
Before we get into valuation, let’s take a look at why $ACN is a quality business </br>
</br>
BALANCE SHEET✅</br>
•Cash & Equivalents: $5.12B</br>
•Long-Term Debt: $71.64M</br>
</br>
$ACN has an excellent balance sheet, an AA- S&P Credit Rating & 174x FFO Interest Coverage Ratio</br>
</br>
RETURN ON CAPITAL✅</br>
•2019: 42.1%</br>
•2020: 30.8%</br>
•2021: 32.0%</br>
•2022: 38.2%</br>
•2023: 33.8%</br>
•LTM: 32.3%</br>
</br>
RETURN ON EQUITY✅</br>
•2019: 37.9%</br>
•2020: 32.1%</br>
•2021: 31.9%</br>
•2022: 32.6%</br>
•2023: 28.5%</br>
•LTM: 27.4%</br>
</br>
$ACN has great return metrics, highlighting the financial efficiency of the business</br>
</br>
REVENUES✅</br>
•2013: $28.56B</br>
•2023: $64.11B</br>
•CAGR: 8.42%</br>
</br>
FREE CASH FLOW✅</br>
•2013: $2.93B</br>
•2023: $8.99B</br>
•CAGR: 11.86%</br>
</br>
NORMALIZED EPS✅</br>
•2013: $4.21</br>
•2023: $11.67</br>
•CAGR: 10.73%</br>
</br>
SHARE BUYBACKS✅</br>
•2013 Shares Outstanding: 713.34M</br>
•LTM Shares Outstanding: 637.95M</br>
</br>
By reducing its shares outstanding ~10.5%, $ACN increased its EPS by ~11.7% (assuming 0 growth)</br>
</br>
PAID DIVIDENDS✅</br>
•2013: $1.62</br>
•2023: $4.65</br>
•CAGR: 11.12% </br>
</br>
MARGINS✅</br>
•LTM Gross Margins: 32.6%</br>
•LTM Operating Margins: 15.8%</br>
•LTM Net Income Margins: 10.9%</br>
</br>
***NOW TO VALUATION 🧠</br>
</br>
As stated above, investors can expect to receive ~4% MORE in EPS & ~11% MORE FCF per share </br>

Using Benjamin Graham’s 2G rule of thumb, $ACN has to grow earnings at a 11.52% CAGR over the next several years to justify its valuation</br>
</br>
Today, analysts anticipate 2024 - 2026 EPS growth over the next few years to be  less than the (11.52%) required growth rate:</br>
</br>
2024E: $12.15 (4.1% YoY) *FY August</br>
2025E: $13.19 (8.6% YoY)</br>
2026E: $14.80 (12.2% YoY)</br>
</br>
$ACN has an excellent track record of meeting analyst estimates ~2 years out, so let’s assume $ACN ends 2026 with $14.80 in EPS & see its CAGR potential assuming different multiples</br>
</br>
25x P/E: $370.00💵 … ~14.2% CAGR</br>
</br>
24x P/E: $355.20💵 … ~12.2% CAGR</br>
</br>
23x P/E: $340.40💵 … ~10.2% CAGR</br>
</br>
22x P/E: $325.26💵 … ~8.0% CAGR</br>
</br>
21x P/E: $310.80💵 … ~5.9% CAGR</br>
</br>
As you can see, we’d have to assume >23x earnings for $ACN to have double digit CAGR potential (~10-year average multiple, yet arguably a bit rich given its growth rate)</br>
</br>
Today at $284💵 it appears that $ACN valuation is being re-rated due to AI-related competitive pressures & it’s growth slowdown, among other things</br>
</br>
To ensure some margin of safety, I’d reconsider $ACN closer to $258💵 or at ~21.00x forward estimates (~9% below today’s price) where I can possibly expect near double digit return potential assuming a 21x end multiple in 2026</br>
</br>
	    
    </div>
</details>
            </div>
    <div>
            <h3>Visa $V</h3>
            <p>
NTM P/E: 26.30x</br>
5-Year Avg: 30.23x</br>
Estimated EPS Growth 2025: 12.4%</br>
Estimated EPS Growth 2026: 13.1%</br>
LTM ROIC: 34.7%</br>
                </p>
	    <details>
    <summary>Visa valuation analysis</summary>
    <div>
        ...
    </div>
</details>
            </div>
	<div>
            <h3>Old Dominion Freight Lines $ODFL</h3>
            <p>
NTM P/E: 27.67x</br>
5-Year Avg: 28.75x</br>
Estimated EPS Growth 2025: 18.5%</br>
Estimated EPS Growth 2026: 10.6%</br>
LTM ROIC: 33.9%</br>
                </p>
	    <details>
    <summary>ODFL valuation analysis</summary>
    <div>
        ...
    </div>
</details>
            </div>
<div>
            <h3>Alphabet $GOOG $GOOGL</h3>
            <p>
NTM P/E: 22.63x</br>
5-Year Avg: 24.60x</br>
Estimated EPS Growth 2025: 13.7%</br>
Estimated EPS Growth 2026: 14.9%</br>
LTM ROIC: 30.2%</br>
                </p>
	    <details>
    <summary>UnitedHealth valuation analysis</summary>
    <div>
        ...
    </div>
</details>
            </div>
<div>
            <h3>S&P Global $SPGI</h3>
            <p>
NTM P/E: 30.65x</br>
5-Year Avg: 29.14x</br>
Estimated EPS Growth 2025: 13.2%</br>
Estimated EPS Growth 2026: 13.1%</br>
LTM ROIC: 9.0%</br>
                </p>
	    <details>
    <summary>S&P valuation analysis</summary>
    <div>
        ...
    </div>
</details>
            </div>
<div>
            <h3>Monster Beverage $MNST</h3>
            <p>
NTM P/E: 28.54x</br>
5-Year Avg: 32.28x</br>
Estimated EPS Growth 2025: 14.2%</br>
Estimated EPS Growth 2026: 13.4%</br>
LTM ROIC: 24.0%</br>
                </p>
	    <details>
    <summary>Monster Beverage valuation analysis</summary>
    <div>
        ...
    </div>
</details>
            </div>
<div>
            
</article>
